Mr. Mackenzie (for himself, Mr. Auchincloss, Mr. Allen, Mrs. McBath, and Mrs. Miller of West Virginia) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.
29 U.S.C. 1002
and
1108 42 U.S.C. 1395w-111, 1395w-112, 1395w-23
and
1395w-27
Document Citations
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026. H.R. 10369. 119th
Cong., 2nd
sess., Introduced in House September 14, 2026. https://www.govinfo.gov/app/details/BILLS-119hr10369ih.
APA
Congress, House of Representatives (2026, September 14). Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 (H.R. 10369 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr10369ih.
MLA
United States, Congress, House of Representatives. Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr10369ih. 119th Congress, H.R. 10369, Introduced in House 14 Sep. 2026.
Bluebook
H.R.10369 - 119th Congress (2025-2026): Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026, H.R.10369, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr10369ih.
